North America Acne Medication Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Therapeutic Class (Retinoids, Benzoyl Peroxide, Antibiotics, Salicylic Acid, and Others), Formulation (Topical Medication and Oral Medication), Type (Prescription Medicine and Over-the-Counter Medicine), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Pharmacies and Drug Stores, Retail Stores, and E-Commerce)

No. of Pages: 121    |    Report Code: BMIRE00030656    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Acne Medication Market

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Acne Medication Market Landscape

4.1 PEST Analysis

4.2 Pricing Analysis of Topical and Oral Medication

4.3 Patient Population Undergoing Acne Treatment

5. North America Acne Medication Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Prevalence of Severe Acne

5.1.2 Launch of Novel Drugs

5.2 Key Market Restraints

5.2.1 Side Effects Associated with Acne Medication

5.3 Key Market Opportunities

5.3.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies

5.4 Future Trends

5.4.1 Upsurge in Need for Organic and Natural Treatments

5.5 Impact of Drivers and Restraints:

6. Acne Medication Market - North America Market Analysis

7. North America Acne Medication Market Analysis - by Therapeutic Class

7.1 Retinoids

7.1.1 Overview

7.1.2 Retinoids: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Benzoyl Peroxide

7.2.1 Overview

7.2.2 Benzoyl Peroxide: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Antibiotics

7.3.1 Overview

7.3.2 Antibiotics: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Salicylic Acid

7.4.1 Overview

7.4.2 Salicylic Acid: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Acne Medication Market Analysis - by Formulation

8.1 Topical Medication

8.1.1 Overview

8.1.2 Topical Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8.2 Oral Medication

8.2.1 Overview

8.2.2 Oral Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Acne Medication Market Analysis - by Type

9.1 Prescription Medicine

9.1.1 Overview

9.1.2 Prescription Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9.2 Over-the-Counter Medicine

9.2.1 Overview

9.2.2 Over-the-Counter Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Acne Medication Market Analysis - by Acne Type

10.1 Non-Inflammatory Acne

10.1.1 Overview

10.1.2 Non-Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10.2 Inflammatory Acne

10.2.1 Overview

10.2.2 Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Acne Medication Market Analysis - by Distribution Channel

11.1 Pharmacies and Drug Stores

11.1.1 Overview

11.1.2 Pharmacies and Drug Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11.2 Retail Stores

11.2.1 Overview

11.2.2 Retail Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11.3 E-Commerce

11.3.1 Overview

11.3.2 E-Commerce: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. North America Acne Medication Market - Country Analysis

12.1 North America

12.1.1 North America: Acne Medication Market - Revenue and Forecast Analysis - by Country

12.1.1.1 North America: Acne Medication Market - Revenue and Forecast Analysis - by Country

12.1.1.2 US

12.1.1.3 US: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12.1.1.3.1 US: Acne Medication Market Breakdown, by Therapeutic Class

12.1.1.3.2 US: Acne Medication Market Breakdown, by Formulation

12.1.1.3.3 US: Acne Medication Market Breakdown, by Type

12.1.1.3.4 US: Acne Medication Market Breakdown, by Acne Type

12.1.1.3.5 US: Acne Medication Market Breakdown, by Distribution Channel

12.1.1.4 Canada

12.1.1.5 Canada: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12.1.1.5.1 Canada: Acne Medication Market Breakdown, by Therapeutic Class

12.1.1.5.2 Canada: Acne Medication Market Breakdown, by Formulation

12.1.1.5.3 Canada: Acne Medication Market Breakdown, by Type

12.1.1.5.4 Canada: Acne Medication Market Breakdown, by Acne Type

12.1.1.5.5 Canada: Acne Medication Market Breakdown, by Distribution Channel

12.1.1.6 Mexico

12.1.1.7 Mexico: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12.1.1.7.1 Mexico: Acne Medication Market Breakdown, by Therapeutic Class

12.1.1.7.2 Mexico: Acne Medication Market Breakdown, by Formulation

12.1.1.7.3 Mexico: Acne Medication Market Breakdown, by Type

12.1.1.7.4 Mexico: Acne Medication Market Breakdown, by Acne Type

12.1.1.7.5 Mexico: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

13.1 Overview

13.2 Growth Strategies in Acne Medication Market

13.3 Organic Growth Strategies

13.3.1 Overview

13.4 Inorganic Growth Strategies

13.4.1 Overview

13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

14.1 Teva Pharmaceutical Industries Ltd

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Almirall SA

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Johnson & Johnson

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Sun Pharmaceutical Industries Ltd

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Bausch Health Companies Inc

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Centro Internacional de Cosmiatria SA de CV

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Galderma SA

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Pfizer Inc

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 GSK Plc

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Viatris Inc

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

14.11 Somar Sapi De CV

14.11.1 Key Facts

14.11.2 Business Description

14.11.3 Products and Services

14.11.4 Financial Overview

14.11.5 SWOT Analysis

14.11.6 Key Developments

14.12 Italmex SA

14.12.1 Key Facts

14.12.2 Business Description

14.12.3 Products and Services

14.12.4 Financial Overview

14.12.5 SWOT Analysis

14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

 

List of Tables

Table 1. North America Acne Medication Market Segmentation

Table 2. Topical Medication

Table 3. Oral Medication

Table 4. Patient Population undergoing Acne Treatment from 2020-2023

Table 5. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Therapeutic Class

Table 6. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Formulation

Table 7. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Type

Table 8. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Acne Type

Table 9. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 10. North America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country

Table 11. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class

Table 12. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation

Table 13. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 14. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type

Table 15. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 16. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class

Table 17. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation

Table 18. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 19. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type

Table 20. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 21. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class

Table 22. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation

Table 23. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 24. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type

Table 25. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 26. Recent Organic Growth Strategies in Acne Medication Market

Table 27. Recent Inorganic Growth Strategies in the Acne Medication Market

Table 28. Glossary of Terms, Acne Medication Market

 

List of Figures

Figure 1. North America Acne Medication Market Segmentation, by Country

Figure 2. PEST Analysis

Figure 3. North America Acne Medication Market - Key Market Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. North America Acne Medication Market Revenue (US$ Million), 2020-2030

Figure 6. North America Acne Medication Market Share (%) - by Therapeutic Class (2022 and 2030)

Figure 7. Retinoids: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Benzoyl Peroxide: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Antibiotics: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Salicylic Acid: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Others: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. North America Acne Medication Market Share (%) - by Formulation (2022 and 2030)

Figure 13. Topical Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Oral Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. North America Acne Medication Market Share (%) - by Type (2022 and 2030)

Figure 16. Prescription Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Over-the-Counter Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. North America Acne Medication Market Share (%) - by Acne Type (2022 and 2030)

Figure 19. Non-Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. North America Acne Medication Market Share (%) - by Distribution Channel (2022 and 2030)

Figure 22. Pharmacies and Drug Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Retail Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. E-Commerce: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. North America: Acne Medication Market - Country, 2022 (US$ Million)

Figure 26. North America: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 27. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)

Figure 28. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)

Figure 29. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)

Figure 30. Growth Strategies in Acne Medication Market

 

 

The List of Companies - North America Acne Medication Market

1. Teva Pharmaceutical Industries Ltd

2. Almirall SA

3. Johnson & Johnson

4. Sun Pharmaceutical Industries Ltd

5. Bausch Health Companies Inc

6. Centro Internacional de Cosmiatria SA de CV

7. Galderma SA

8. Pfizer Inc

9. GSK Plc

10. Viatris Inc

11. Somar Sapi De CV

12. Italmex SA